Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Apr 05, 2023
The Drug Delivery Devices Market is evolving at an immense pace owing to ongoing developments in the domain. Several major companies are developing new devices
Read More...
Apr 03, 2023
DAYBUE (trofinetide) by Acadia Pharmaceuticals & Neuren Pharmaceuticals became the first & only FDA-approved drug for Rett syndrome treatment.
Read More...
Mar 29, 2023
In recent years, Probiotics and prebiotics products have gained intense development and attention from the scientific, researchers, and healthcare giants due to their beneficial roles in maintaining human health. Several clinical studies have demonstrated a positive effect of probiotics on gastrointestinal diseases...
Read More...
Mar 27, 2023
SHTG and FCS treatment market to evolve with the launch of ApoC-III inhibiting drugs, Olezarsen (Ionis) and ARO-APOC3 (Arrowhead). Clinical…
Read More...
Mar 24, 2023
With increasing MedTech companies, their products, & regulatory approvals, we can see increased adoption of robotics in surgery.
Read More...
Mar 22, 2023
Orthopedic Implants Market is expected to grow at an immense pace. Companies are working to develop new implants to fulfill the demand
Read More...
Mar 20, 2023
100+ pharma companies are working to assess challenges & seek opportunities that could influence obesity treatment scenario in coming years.
Read More...
Mar 17, 2023
Immuno-oncology (I-O) therapeutics, despite yielding effective outcomes, remain associated with a risk of failure & adverse side effects.
Read More...
Mar 15, 2023
The applications of Artificial Intelligence (AI) In Drug Commercialization is growing at an unprecedented rate. It provides several benefits
Read More...
Mar 13, 2023
Owning to evolution of genomic profiling technologies, cancer biomarkers are becoming increasingly relevant in management of cancer patients.
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper